Transactions
Showing 703-711 of 974 items
-
US$201m
BioQ Pharma
Co-Manager (Follow-on)
-
US$36m
TiGenix
Lead Manager (IPO)
-
US$200m
Nant Health
Co-Manager (Convertible Notes)
-
US$75m
Obalon Therapeutics
Joint Bookrunner (IPO)
-
US$123m
iRhthym Technologies
Co-Manager (IPO)
-
US$172m
Advanced Accelerator Applications
Co-Manager (Follow-on)
-
N/a
Pure Communications
Financial Advisor to Pure Communications on its sale to W2O Group
-
US$201m
Sage Therapeutics
Co-Manager (Follow-on)
-
US$75m
Aquinox Pharmaceuticals, Inc.
Joint Bookrunner (Follow-on)
